STUDY OF RITUXIMAB EFFICACY PREDICTORS IN PATIENTS WITH SYSTEMIC SCLEROSIS WITH INTERSTITIAL LUNG DISEASE

被引：0
|
作者：
Koneva, Olga
Ananyeva, Lidia
Garzanova, Liudmila
Desinova, Oxana
Ovsynnikova, Olga
Starovoytova, Mayya
机构：
来源：
CHEST | 2021年 / 160卷 / 04期
关键词：
D O I：
10.1016/j.chest.2021.07.1897
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2148A / 2148A
页数：1
相关论文
共 50 条
  • [1] Efficacy of Rituximab in Systemic Sclerosis with Interstitial Lung Disease
    Onat, Ahmet Mesut
    Zengin, Orhan
    Aksoy, Savas
    Onder, Mustafa Erkut
    Sacinti, Koray Gorkem
    Kisacik, Bunyamin
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
    Mohammed, Abdel Gaffar A.
    Alshihre, Ammar
    Al-Homood, Ibrahim Abdulrazag
    ANNALS OF THORACIC MEDICINE, 2017, 12 (04) : 294 - 297
  • [3] RITUXIMAB AND CYCLOPHOSPHAMIDE COMPARISON FOR EFFICACY AND SAFETY IN THE PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Koneva, Olga
    Ananyeva, Lidia P.
    Garzanova, Liudmila
    Desinova, Oxana
    Ovsyannikova, Olga
    Starovoytova, Mayya
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 169 - 169
  • [4] COMPARISON OF THE EFFICACY OF TWO RITUXIMAB REGIMENS IN THE PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Koneva, Olga
    Ananyeva, Lidia P.
    Garzanova, Liudmila
    Desinova, Oxana
    Ovsyannikova, Olga
    Starovoytova, Mayya
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 450 - 450
  • [5] Predictors of progression in systemic sclerosis patients with interstitial lung disease
    Distler, Oliver
    Assassi, Shervin
    Cottin, Vincent
    Cutolo, Maurizio
    Danoff, Sonye K.
    Denton, Christopher P.
    Distler, Jorg H. W.
    Hoffmann-Vold, Anna-Maria
    Johnson, Sindhu R.
    Ladner, Ulf Mueller
    Smith, Vanessa
    Volkmann, Elizabeth R.
    Maher, Toby M.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (05)
  • [6] THE STUDY OF NINTEDANIB EFFICACY IN PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Koneva, Olga A.
    Garzanova, Liudmila
    Ananyeva, Lidia
    Ovsyannikova, Olga
    Starovoytova, Mayya
    Desinova, Oxana
    Shayakhmetova, Rushana
    CHEST, 2023, 164 (04) : 5480A - 5481A
  • [7] Rituximab for the treatment of systemic sclerosis-interstitial lung disease
    Hughes, Michael
    Denton, Christopher P.
    Khanna, Dinesh
    RHEUMATOLOGY, 2021, 60 (02) : 489 - 491
  • [8] Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial
    Kuzumi, Ai
    Oba, Koji
    Ebata, Satoshi
    Kashiwabara, Kosuke
    Ueda, Keiko
    Uemura, Yukari
    Watadani, Takeyuki
    Fukasawa, Takemichi
    Miura, Shunsuke
    Yoshizaki-Ogawa, Asako
    Kage, Hidenori
    Sato, Shinichi
    Yoshizaki, Ayumi
    RHEUMATOLOGY, 2025,
  • [9] THE INFLUENCE OF INTERSTITIAL LUNG DISEASE EXTENT IN PATIENTS WITH SYSTEMIC SCLEROSIS ON THE EFFECTIVENESS OF RITUXIMAB THERAPY
    Koneva, Olga A.
    Desinova, Oxana
    Ovsyannikova, Olga
    Garzanova, Liudmila
    Starovoytova, Mayya
    Ananyeva, Lidia
    CHEST, 2023, 164 (04) : 5475A - 5476A
  • [10] RITUXIMAB IN SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE, A CASE SERIES OF 18 PATIENTS
    Guzelant, G.
    Melikoglu, M.
    Musellim, B.
    Yilmaz, D. D.
    Fresko, I.
    Seyahi, E.
    Hatemi, G.
    Ugurlu, S.
    Harnuryudan, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1274 - 1274
12345